The biological mechanisms by which physical activity might have an impact on outcome/prognosis after a breast cancer diagnosis

Exercise and Cancer Survivorship: Impact on Health Outcomes and Quality of Life

Volumn , Issue , 2010, Pages 97-111

  Irwin, Melinda L ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871752503     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-1173-5_6     Document Type: Chapter

References (59)

1. ACS. (2006) Breast Cancer Facts and Figures: 2006-2007. American Cancer Society I, Atlanta.
2. Friedenreich CM. (2001) Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomark Prev 10(4):287-301.
3. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. (2005) Physical activity and survival after breast cancer diagnosis. J Am Med Assoc 293(20):2479-2486.
4. Holick CN, Newcomb PA, Trentham-Dietz A, et al. (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomark Prev 17(2):379-386.
5. Irwin ML, Smith A, McTiernan A, et al. (2008) Influence of pre- and post-diagnosis physical activity on survival in breast cancer survivors: the health, eating, activity, and lifestyle (HEAL) study. J Clin Oncol 26(24):1-7.
6. Pierce JP, Stefanick ML, Flatt SW, et al. (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25(17):2345-2351.
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. NEJM 348(17):1625-1638.
8. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92(4):720-729.
9. Kroenke CH, Chen WY, Rosner B, Holmes MD. (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370-1378.
10. Irwin ML, McTiernan A, Baumgartner RN, et al. (2005) Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 23(4):774-782.
11. Caan BJ, Emond JA, Natarajan L, et al. (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99(1):47-57.
12. Irwin ML, Yasui Y, Ulrich CM, et al. (2003) Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. J Am Med Assoc 289(3):323-330.
13. Irwin ML, Alvarez-Reeves M, Cadmus L, et al. 2009 Randomized controlled trial of exercise on body fat, lean mass, and bone mineral density in breast cancer survivors (Under review)
14. Schmitz KH, Ahmed RL, Hannan PJ, Yee D. (2005) Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomark Prev 14(7):1672-1680.
15. Goodwin PJ, Ennis M, Pritchard KI, et al. (2002) Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20(1):42-51.
16. Irwin MLBL, McTiernan A, et al. (2007) Associations between fasting c-peptide and breast cancer death: the Health, Eating, Activity, and Lifestyle (HEAL) Study. AACR Frontiers in Cancer Prevention Meeting, December 2007, Abstract B99.
17. Pollak MNCJ, Shepherd L, et al. (2006) Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial. J Clin Oncol 24: (suppl 18S, abstr 524).
18. Gray SG, Stenfeldt Mathiasen I, De Meyts P. (2003) The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?. Horm Metab Res 35(11-12):857-871.
19. Yu H, Rohan T. (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92(18):1472-1489.
20. Hankinson S, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. (1998) Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351:1393-1396.
21. Goodwin PJ, Ennis M, Pritchard KI, et al. (2002) Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat 74(1):65-76.
22. Ligibel JA, Campbell N, Partridge A, et al. (2008) Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 26(6):907-912.
23. Irwin ML, Varma K, Cadmus L, et al. (2009) Randomized controlled trial of exercise on insulin and IGFs in breast cancer survivors. Cancer Epidemiol Biomark Prev 18(1):306-313.
24. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. (2003) Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomark Prev 12(8):721-727.
25. Frank LL, Sorensen BE, Yasui Y, et al. (2005) Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 13(3):615-.
26. Goodyear L. (1998) KBE, glucose transport, and insulin sensitivity. Ann Rev Med 49:235-261.
27. Key T, Appleby P, Barnes I, Reeves G. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606-616.
28. Howell A, Cuzick J, Baum M, et al. (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365(9453):60-62.
29. Thurlimann B, Keshaviah A, Coates AS, et al. (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747-2757.
30. McTiernan A, Tworoger SS, Ulrich CM, et al. (2004) Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 64(8):2923-2928.
31. McTiernan A, Wu L, Chen C, et al. (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 14(9):1662-1677.
32. McTiernan A, Rajan KB, Tworoger SS, et al. (2003) Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21(10):1961-1966.
33. Irwin ML. Alvarez-Reeves M., Cadmus L, et al. (2008) RCT of exercise on sex hormones in breast cancer survivors. AACR Frontiers in Cancer Prevention Meeting, December, 2008.
34. Vona-Davis L. (2007) RDA, paracrine, and autocrine factors in breast cancer risk and progression. Endocrine-Related Cancer 14:189-206.
35. Jarde T, Caldefie-Chezet F, Damez M, et al. (2008) Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma. Oncol Rep 19(4):905-911.
36. Housa DHJ, Vernerova Z, Haluzik M. (2006) Adipocytokines and cancer. Physiol Res 55:233-244.
37. Nicolini A, Carpi A, Rossi G. (2006) Cytokines in breast cancer. Cytokine Growth Factor Rev 17:325-337.
38. Irwin ML, McTiernan A, Bernstein L, et al. (2005) Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomark Prev 14(12):2881-2888.
39. Miyoshi YFT, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699-5704.
40. Arditi JD, Venihaki M, Karalis KP, Chrousos GP. (2007) AnTiproliferative effect of adiponectin on MCF 7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metabol Res 39(1):9-13.
41. Miyoshi Y, Funahashi T, Kihara S, et al. (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9(15):5699-5704.
42. Irwin ML, Alvarez-Reeves M, Cadmus L, et al. (2009) RCT of exercise on leptin and adiponectin in breast cancer survivors. Obesity (Under review).
43. Ardizzoia ALP, Brivio F, et al. (1992) Tumor necrosis factor in sold tumors: increased blood levels in metastatic disease. J Biol Regul Homeost Agents 6:103.
44. Pierce BL, Neuhouser ML, Wener MH, et al. (10 April 2008) Correlates of circulating Creactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 114:155-167.
45. Zhang SM, Lin J, Cook NR, et al. (2007) C-reactive protein and risk of breast cancer. J Natl Cancer Inst 99(11):890-894.
46. De Nardo DG, Coussens LM. (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9(4):212.
47. McMillan DCEM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. (2001) Measurement of the systematic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41(1&2):64-69.
48. Garcia-Tunon IRM, Ruiz A, Fraile B, Paniagua R, Royuela M. (2006) Role of tumor necrosis factor-a and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci 97:1044-1049.
49. Knupfer H, Preib R. (2007) Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 102:129-135.
50. Mohamed-Ali VGS, Rawesh A, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a in vivo. J Clin Endocrinol Metabol 82:4196-4200.
51. Fairey AS, Courneya KS, Field CJ, et al. (2005) Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun 19(5):381-388.
52. Jones S, Hesselsweet S, Yu H, Irwin ML. (2009) Randomized controlled trial of exercise on inflammation in breast cancer survivors. J Cancer Survivorship (Under review).
53. Fischer CPBA, Perstrup LB, Eskildsen P, Pedersen BK. (2007) Plasma levels of interleukin-6 and c-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 17:580-587.
54. Olson TPDD, Leon AS, Schmitz KH. (2007) Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obesity 31:996-1003.
55. Dekker MJLS, Hudson R, et al. (2007) An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabol Clin Exp 56:332-338.
56. Kasapis C, Thompson PD. (2005) The effects of physical activity on serum c-reactive protein and inflammatory markers. J Am College Cardiol 45(10):1563-1569.
57. Hursting SD, Lashinger LM, Colbert LH, et al. (2007) Energy balance and carcinogenesis: underlying pathways and targets for intervention. Curr Cancer Drug Targets 7(5):484-491.
58. Fairey AS, Courneya KS, Field CJ, Mackey JR. (2002) Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 94(2):539-551.
59. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. (2005) Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 98(4):1534-1540.